Sun Pharmaceutical Industries Inc recalls Clindamycin Phosphate USP
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
- Products
-
- Clindamycin Phosphate USP
- Where it was sold
-
Nationwide in the USA.
Nationwide
- About this recall
- Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4